Navigation Links
Longer-Lived Rodents Have Lower Levels of Thyroid Hormone

The thyroid may play an important role in longevity, with longer-lived rodents showing significantly lower levels of a thyroid hormone that speeds metabolism, a new study has found.//

The study further strengthens the theory that the faster an animal’s metabolism, the shorter its life, and vice versa, said Mario Pinto, the study’s lead author. The thyroid releases hormones that regulate metabolic rate.

“Thyroid hormones are key regulators of metabolism and have been widely implicated to influence longevity,” the authors wrote. Pinto will present the study “Differential thyroid hormone activity in rodents with different life spans” at a poster session Oct. 9 at Comparative Physiology 2006: Integrating Diversity. The study was carried out by Pinto and Rochelle Buffenstein, City College of New York.

Thyroid key to metabolic rate

The thyroid gland produces thyroxine (T4) which converts to triiodothyronine (T3) in the presence of iodine. T3 is the active component of T4 and is the key hormone in regulating metabolism, Pinto said. When an animal becomes cold, for example, its body converts T4 to T3 to speed metabolism and warm the body, he explained.

'Mice strains that exhibit extended longevity tend to have lower thyroid hormone concentrations than shorter living strains,' the authors wrote. 'Significant declines in thyroid hormone correlate well with enhanced maximum lifespan.'

The study compared the levels of these thyroid hormones among four groups of rodents with different life spans: mice, guinea pigs, Damara mole-rats and naked mole-rats. Mice live to about three and a half years; guinea pigs live to six years; Damara mole-rats to 15 years; and naked mole-rats to 28 years.

The animals were of different ages, but at comparable points in their life spans. For example, the mole-rats, which live 28 years, were two years old. The mice, which live about 3.5 years, were six months old. The s
'"/>




Page: 1 2

Related medicine news :

1. Rodents to be replaced with Dogs for cancer Research
2. Glucose Causes Death of Brain Cells in Rodents Following Hypoglycemic Coma
3. Simvastatin Plus Niacin May Lower Heart Risks
4. Ritalin May Lower Cocaine Abuse
5. Eating More Often May Help Lower Cholesterol
6. Lower surgical volume linked to higher death rate
7. Lowering blood pressure beneficial for PAD patients
8. Lower chance of bone fracture with Vitamin D supplementation
9. Tea Pill Lowers Cholesterol
10. Aspirin Lowers Leukemia Risk
11. Almonds Help Lower Cholesterol
Post Your Comments:
(Date:7/25/2008)...e/ -- Klafter & Olsen LLP has filed a,class action...re" or the,"Company") (Nasdaq: ARTC ) and certain...e Western District of Texas on behalf of all perso...roCare from January 24, 2008,through July 18, 2008...ll,persons or entities who purchased call options ...
(Date:7/25/2008)...iretroviral therapy may be due to genetic factors ...A new study challenges the long-held belief that t...em,s ability to restore itself after HIV patients ...apy (HAART). , From 50 percent to 90 percent of...V. Intravenous drug use is the main cause of both ...
(Date:7/25/2008)...- BeaconEquity.com announces the,availability of T...rs can view all of the daily trading notes for fre...,s Trade Alerts include: DUSA Pharmaceuticals Inc..... (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,NOVA), A...daq: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )., J...
(Date:7/25/2008)...gnificant Improvements in Members, Health, ATLANT...er in health,care quality management solutions for...s entered into a long-term agreement with Wellmark...tion on Quality(SM) Incent and,Reward Best Practic...d,primary care clinicians to promote improved qual...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
... fish at least once a month can minimise the risk ...d researchers. Around 607 participants developed...dy involving more than 43,005 men aged 39 to 76. I...clot that blocks the blood vessel supplying the br...
...ug fluvoxamine has been found by researchers to be...od shifts in women with borderline personality dis...renic, non-bipolar women with borderline// persona...onducted by researchers from various universities ...
...evious research evidence that HRT could reduce ris...n reversed by a recent study of 1000 women of ages...r in the United Kingdom.The aim of the study was t...and progesterone reduced the risk of future heart ...
...chers in there study are trying to observe why su...e but studies are ongoing. It's long been known th...and other mental functions after an operation// - ...function (POCD).Often relatives will say that the ...
Other Medicine News:
(Date:7/22/2008)...July 22 /- Following a,thor...rd of Progen,Pharmaceuticals Limited (ASX: PGL; Na...ed the PI-88 phase 3 study in liver cancer. Progen...existing portfolio of compounds and,the company wi...nd,opportunities through Merger & Acquisition acti...
(Date:7/22/2008)...herapeutics Development Initiative bring MJFF,s,cu...eadline January 20,2009, NEW YORK, July 22 /PRNe...eed delivery of transformative treatments and a cu...ndation for Parkinson,s Research has awarded,$2.7 ...teams. The awards,were granted under MJFF,s Therap...
(Date:7/22/2008)...tudy Confirms Tyrima Exhibits Excellent Drug-Like ...Results Support Initiation of Phase II Clinical Tr...Newswire/ -- CeNeRx BioPharma,Inc., a clinical st...ive,treatments for diseases of the central nervous... candidate Tyrima(TM) into Phase II trials for the...
(Date:7/22/2008)...Calif., July 22 /- Hyperion,Therapeut...tient enrollment,in its Phase 1/2 clinical trial t...avenging effects of HPN-100 (formally called GT4P)...ients with urea cycle disorders,(UCD). The company...quarter,of this year., (Logo: http://www.newscom...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Many African Americans have a gene that prolongs life after heart failure 2966 1Many African Americans have a gene that prolongs life after heart failure 2966 2Many African Americans have a gene that prolongs life after heart failure 2966 3Many African Americans have a gene that prolongs life after heart failure 2966 4Allergies Can Dig Into Gardenings Fun 17255 1Allergies Can Dig Into Gardenings Fun 17255 2BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance 4712 1BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance 4712 2BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance 4712 3Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 1Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 2Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 3Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 4
...BRIDGE, Mass.--(BUSINESS WIRE)--Apr 12, 2007 - AVE...ny focused on the,discovery and development of nov...t it will present a total of 12 oral and poster,pr... Research,(AACR) Annual Meeting on April 14-18, 20...ted to share with the cancer community the,pioneer...
...NDON, April 12, 2007--The costs of eradicating,pol...while high in,the short term, are much lower than ...s without eradication. And a recently developed,mo...ive against,type 1 poliomyelitis than an existing ...rticles published Online and in an upcoming,issue ...
Other Medicine Technology:AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical,Pipeline to Be Featured at AACR 2AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical,Pipeline to Be Featured at AACR 3Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3
Stainless Steel
2 Sided Pivoted Closed Ring Design,Pointed And Smooth Sides; in stainless steel.
The e.cam single-detector system offers general purpose scanning flexibility with unrestricted access for gurneys and wheelchairs. This cost-effective system features a clinically versatile open gant
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM
Medicine Products: